DavidALiebnerMD

Clinical Trials

• Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09

  Completed

  Phase 1

• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01

  Completed

  Phase 1, Phase 2

• An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry Start of enrollment: 2015 Jul 01

  Recruiting

• Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma Start of enrollment: 2016 Dec 06

  Completed

  Phase 2

• MAGE-A4ᶜ¹º³²T for Multi-Tumor Start of enrollment: 2017 May 15

  Active, not recruiting

  Phase 1

• Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2019 Aug 13

  Recruiting

  Phase 2

• Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) Start of enrollment: 2023 Nov 29

  Recruiting

  Phase 3

  Roles: Contact, Principal Investigator

• Join now to see all